Comparison of efficacy between intravenous clonidine and dexmedetomidine as pre-medication in attenuating hemodynamic stress responses during laparoscopic cholecystectomy

Background: Laparoscopic cholecystectomy is a commonly performed surgery and stable intraoperative hemodynamic status is desirable during pneumoperitonium. Clonidine and dexmedetomidine (alpha-2 adrenergic agonist) were used in this study to attenuate the stress response of pneumoperitoneum because alpha-2 adrenergic agonists help in the attenuation of neuroendocrine and hemodynamic responses to surgery and anesthesia, due to its sympatholytic action. Aims and Objectives: The aims and objectives of the study are to conduct a comparative evaluation of clonidine and dexmedetomidine as pre-anesthetic medication for the attenuation of hemodynamic changes during laparoscopic cholecystectomy surgeries. Materials and Methods: Eighty patients of either sex, aged 20–50 years, complying to the American Society of Anesthesiologists physical status I-II, scheduled for elective laparoscopic cholecystectomy under general anesthesia were divided into two equal groups to receive either clonidine 1 mg/kg (Group-C, n=40) or dexmedetomidine 1 mg/kg (Group-D, n=40), both injected through intravenous route as 15 mL volume with normal saline. Heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, and SpO2 were measured before and after giving the study drugs, before and immediately after pneumoperitoneum, and then, at 10, 20, 30, 40, and 50 min of pneumoperitoneum. Results: Statistically significant difference was observed in heart rate in the dexmedetomidine group constantly since giving study drug, immediately after the creation of pneumoperitoneum, and then, 10, 20, 30, 40, and 50 min after pneumoperitoneum. Systolic, diastolic, and mean blood pressures were found to be significantly lower in Group D (except after administering study drug), immediately after creating pneumoperitoneum, and 10, 20, 30, 40, and 50 min after pneumoperitoneum. Conclusion: Dexmedetomidine as pre-medication is more efficacious in attenuating hemodynamic stress responses in laparoscopic cholecystectomy surgeries compared to clonidine as pre-medication

Effect of dexmedetomidine as adjuvant in ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded and randomized controlled study

Background and Aims: Different additives have been used to prolong brachial plexus block. We evaluated the effect of adding dexmedetomidine to ropivacaine for supraclavicular brachial plexus blockade. The primary endpoints were the onset and duration of sensory and motor block and duration of analgesia. Materials and Methods: A total of 84 patients (20-50 years) posted for elective forearm and hand surgery under supraclavicular brachial plexus block were divided into two equal groups (Group R and RD) in a randomized, double-blind fashion. In group RD (n = 42) 30 ml 0.5% ropivacaine +1 ml (100 μg) of dexmedetomidine and group R (n = 42) 30 ml 0.5% ropivacaine +1 ml normal saline were administered in supraclavicular block. Sensory and motor block onset times and block durations, time to first analgesic use, total analgesic need, postoperative visual analog scale (VAS), hemodynamics and side-effects were recorded for each patient. Results: Though with similar demographic profile in both groups, sensory and motor block in group RD (P < 0.05) was earlier than group R. Sensory and motor block duration and time to first analgesic use were significantly longer and the total need for rescue analgesics was lower in group RD (P < 0.05) than group R. Post-operative VAS value at 12 h were significantly lower in group RD (P < 0.05). Intra-operative hemodynamics were significantly lower in group RD (P < 0.05) without any appreciable side-effects. Conclusion: It can be concluded that adding dexmedetomidine to supraclavicular brachial plexus block increases the sensory and motor block duration and time to first analgesic use, and decreases total analgesic use with no side-effects

Tryptamine-Gallic Acid Hybrid Prevents Non-steroidal Anti-inflammatory Drug-induced Gastropathy

Non-steroidal anti-inflammatory drugs (NSAIDs) induce gastropathy by promoting mitochondrial pathology, oxidative stress, and apoptosis in gastric mucosal cells. We have synthesized SEGA (3a), a tryptamine-gallic acid hybrid, which prevents NSAID-induced gastropathy by preventing mitochondrial oxidative stress, dysfunction, and apoptosis. SEGA (3a) bears an immense therapeutic potential against NSAID-induced gastropathy. This novel molecule is a significant addition in the discovery of gastroprotective drugs

Abstracts of National Conference on Research and Developments in Material Processing, Modelling and Characterization 2020

This book presents the abstracts of the papers presented to the Online National Conference on Research and Developments in Material Processing, Modelling and Characterization 2020 (RDMPMC-2020) held on 26th and 27th August 2020 organized by the Department of Metallurgical and Materials Science in Association with the Department of Production and Industrial Engineering, National Institute of Technology Jamshedpur, Jharkhand, India. Conference Title: National Conference on Research and Developments in Material Processing, Modelling and Characterization 2020Conference Acronym: RDMPMC-2020Conference Date: 26–27 August 2020Conference Location: Online (Virtual Mode)Conference Organizer: Department of Metallurgical and Materials Engineering, National Institute of Technology JamshedpurCo-organizer: Department of Production and Industrial Engineering, National Institute of Technology Jamshedpur, Jharkhand, IndiaConference Sponsor: TEQIP-